Health Care sector company Baxter International posted a 2.91% performance today, while the S&P 500 returned 0.66%.
13 analysts are following Baxter International and have set target prices ranging from $40.0 to $63.2 per share. On average, they have given the company a rating of buy. At today's prices, BAX is trading -19.08% away from its average analyst target price of $48.48 per share.
Over the last year, BAX shares have gone down by -50.29%, which represents a difference of -37.08% when compared to the S&P 500. The stock's 52 week high is $79.03 per share and its 52 week low is $37.35. Although Baxter International's average free cash flow over the last four years has been $1,187,200,000.0, they have been decreasing at an average rate of -10.08%. For this reason, investors may continue to shun the stock.
| Date Reported | Cash Flow from Operations (k) | Capital Expenditures (k) | Free Cash Flow (k) | YoY Growth |
|---|---|---|---|---|
| 2022-12-31 | $1,211,000 | $679,000 | $532,000 | -64.03% |
| 2021-12-31 | $2,222,000 | $743,000 | $1,479,000 | 27.61% |
| 2020-12-31 | $1,868,000 | $709,000 | $1,159,000 | -17.68% |
| 2019-12-31 | $2,104,000 | $696,000 | $1,408,000 | 3.68% |
| 2018-12-31 | $2,017,000 | $659,000 | $1,358,000 | n/a |
